Sandro Alves, Guillaume Churlaud, David Klatzmann, Nathalie Cartier. Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.
Brain - A Journal of Neurology , Oxford University Press (OUP), 2017, 140 (7), pp.e40 - e40.
⟨10.1093/brain/awx109⟩.
⟨inserm-01617417⟩